Redwood Grove Capital’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-147,705
Closed -$944K 23
2025
Q1
$944K Hold
147,705
0.34% 23
2024
Q4
$1.75M Hold
147,705
0.54% 23
2024
Q3
$4.09M Buy
147,705
+14,495
+11% +$363K 1.11% 22
2024
Q2
$3.18M Hold
133,210
0.99% 26
2024
Q1
$2.34M Hold
133,210
0.73% 27
2023
Q4
$2.1M Hold
133,210
0.78% 25
2023
Q3
$1.15M Hold
133,210
0.46% 27
2023
Q2
$1.05M Hold
133,210
0.44% 27
2023
Q1
$992K Hold
133,210
0.47% 27
2022
Q4
$1.57M Hold
133,210
0.78% 25
2022
Q3
$1.23M Buy
133,210
+60,000
+82% +$727K 0.67% 26
2022
Q2
$723K Hold
73,210
0.39% 25
2022
Q1
$2.55M Buy
+73,210
New +$2.38M 1.27% 24

Other funds holding ASPN

Redwood Grove Capital's ASPN Position: Q2 2025 in Review

Redwood Grove Capital sold out of Aspen Aerogels (ASPN) in Q2 2025, closing a stake of 147,705 shares — an estimated $944K sold.

Redwood Grove Capital first reported a position in ASPN in Q1 2022 and held it in 13 quarters. The position peaked at $4.09M in Q3 2024. 182 funds tracked by Wall St. Rank hold ASPN as of Q2 2025.

  • Redwood Grove Capital reported no remaining Aspen Aerogels position as of Q2 2025 after selling out during the quarter.
  • Redwood Grove Capital sold 147,705 Aspen Aerogels shares in Q2 2025, an estimated $944K.
  • Redwood Grove Capital first reported a position in Aspen Aerogels in Q1 2022 and held it in 13 quarters.
  • Redwood Grove Capital's Aspen Aerogels position peaked at $4.09M in Q3 2024.
  • 182 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2025.

Based on Redwood Grove Capital's 13F filing for Q2 2025, filed 14 Aug 2025.